finanzen.net
19.09.2018 18:15
Bewerten
(0)

Global Hemostats Market 2018-2023 by Product, Application, Formulation - Market is Expected to Reach USD 3.03 Billion

DRUCKEN

DUBLIN, Sept. 19, 2018 /PRNewswire/ --

The "Hemostats Market by Product (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), Application (Gynecology, Neurology, Cardiovascular, Reconstructive), Formulation (Powder, Matrix & Gel, Sheets & Pads) - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

The global hemostats market is expected to reach USD 3.03 billion by 2023 from USD 2.27 billion in 2018, at a CAGR of 6.0%

Growth in this market is driven by the increasing number of surgical procedures, growing number of regulatory approvals, increasing incidence of sports-related injuries and spinal ailments, and rising focus on effective blood loss management in patients during surgeries. In addition, the emerging markets and growth in the number of hospitals and surgical centers are expected to offer further growth opportunities for players operating in the hemostats market during the forecast period.

The global hemostats market is segmented by product, application, formulation, and region.

Based on applications, the hemostats market is segmented into neurological surgery, cardiovascular surgery, general surgery, orthopedic surgery, thoracic surgery, gynecological surgery, urological surgery, and reconstructive surgery. The orthopedic surgery segment is expected to account for the largest share of the hemostats market in 2018. The growing geriatric population, increasing incidence of sports injuries, and the growing prevalence of lifestyle disorders (such as arthritis, osteoporosis, and obesity) are some of the major factors responsible for the growth in the number of orthopedic surgeries performed globally. The growing number of orthopedic surgeries is in turn expected to support the growth of dependent markets, such as the hemostats market for orthopedic applications.

Based on product, the hemostats market is segmented into thrombin-based hemostats, oxidized regenerated cellulose-based hemostats, combination hemostats, gelatin-based hemostats, and collagen-based hemostats. The thrombin-based hemostats segment is expected to account for the largest share of the market in 2018. The large share of this market segment can primarily be attributed to the wide range of advantages associated with the use of thrombin-based hemostats.

Based on formulation, the hemostats market is further segmented into matrix & gel hemostats, sheet & pad hemostats, sponge hemostats, and powder hemostats. In 2018, the matrix & gel hemostats segment is expected to account for the largest share of the hemostats market. The large share of this market segment can primarily be attributed to the advantages associated with the use of these formulations, such as lightweight and ease of use. Sponge hemostats, on the other hand, are expected to witness the highest growth in the market during the forecast period. Market growth can largely be attributed to the growing acceptance of these formulations by end users.

The major players in the hemostats market include CR Bard, Inc. (US). B. Braun Melsungen AG (Germany), Baxter International, Inc. (US), Integra LifeSciences (US), Marine Polymer Technologies, Inc. (US), Teleflex (US), Ethicon, Inc. (US), Pfizer, Inc. (US), Z-Medica LLC (US), and Gelita Medical GmbH (Germany).

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

4.1 Hemostats: Market Overview
4.2 Asia Pacific: Hemostats Market, By Formulation (2018)
4.3 Hemostats Market, By Region (2018)
4.4 Geographical Snapshot of the Hemostats Market

5 Market Overview

5.1 Introduction
5.2 Market Dynamics
5.3 Drivers
5.3.1 Increasing Number of Surgical Procedures
5.3.2 Growing Number of Regulatory Approvals
5.3.3 Increasing Incidence of Sports-Related Injuries and Spinal Ailments
5.3.4 Rising Focus on Effective Blood Loss Management in Patients During Surgeries
5.4 Market Opportunities
5.4.1 Growth in the Number of Hospitals & Surgical Centers
5.4.2 Emerging Markets
5.5 Market Restraints
5.5.1 Product Recalls
5.5.2 Highly Consolidated Market
5.6 Market Challenges
5.6.1 Dearth of Skilled Personnel
5.6.2 High Cost of Hemostats

6 Hemostats Market, By Product

6.1 Introduction
6.2 Thrombin-Based Hemostats
6.3 Oxidized Regenerated Cellulose-Based Hemostats
6.4 Combination Hemostats
6.5 Gelatin-Based Hemostats
6.6 Collagen-Based Hemostats

7 Hemostats Market, By Formulation

7.1 Introduction
7.2 Matrix & Gel Hemostats
7.3 Sheet & Pad Hemostats
7.4 Sponge Hemostats
7.5 Powder Hemostats

8 Hemostats Market, By Application

8.1 Introduction
8.2 Orthopedic Surgery
8.3 General Surgery
8.4 Neurological Surgery
8.5 Cardiovascular Surgery
8.6 Reconstructive Surgery
8.7 Gynecological Surgery
8.8 Other Surgeries

9 Hemostats Market, By Region

10 Competitive Landscape

10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Scenario
10.3.1 Product Launches and Approvals
10.3.2 Acquisitions
10.3.3 Agreements
10.3.4 Expansions

11 Company Profiles

11.1 C. R. Bard
11.2 B.Braun
11.3 Baxter
11.4 Integra Lifesciences
11.5 Marine Polymer Technologies
11.6 Pfizer
11.7 Gelita Medical GmbH
11.8 Z-Medica, LLC
11.9 Ethicon (Subsidiary of Johnson & Johnson)
11.10 Teleflex Incorporated

For more information about this report visit https://www.researchandmarkets.com/research/pr73sp/global_hemostats?w=5

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/global-hemostats-market-2018-2023-by-product-application-formulation---market-is-expected-to-reach-usd-3-03-billion-300715383.html

SOURCE Research and Markets

Anzeige
Anzeige
Börse Stuttgart Anlegerclub

Die richtige Strategie für die Börsenkrise

Stecken Sie nicht den Sand in den Kopf, sondern kaufen Sie die richtigen Aktien. Erfahren Sie im aktuellen Anlegermagazin mehr über attraktive Qualitätsaktien und zyklische Aktien
Kostenfrei registrieren und lesen!

Heute im Fokus

DAX geht tiefer ins Wochenende -- Wall Street beendet Tag leichter -- Trump verschiebt Entscheidung über EU-Autozölle -- Fresenius legt große Übernahmen auf Eis -- Pinterest, thyssen, Dürr im Fokus

Unfallermittler: Teslas 'Autopilot' war bei Todescrash eingeschaltet. Arcelor-Aktien erneut sehr schwach - Längste Verlustserie seit 1997. Siemens und Philips anscheinend in Brasilien im Visier des FBI. Juventus Turin trennt sich von Trainer Allegri. Labour erklärt Brexit-Gespräche mit Regierung für gescheitert. Salzgitter, Klöckner, thyssen: Stahlwerte-Aktien schwächeln weiter. Zalando-Aktie unter Druck - UBS skeptisch mit Blick auf Wachstum.

Die 5 beliebtesten Top-Rankings

Diese Aktien hat Warren Buffett im Depot
Die Änderungen unter den Top-Positionen
Die erfolgreichsten Kinofilme der letzten 25 Jahre
Welche Titel knackten die Milliardenmarke an den Kinokassen?
In diesen Berufen bekommt man das höchste Gehalt
Mit welchem Beruf kommt man am ehesten an die Spitze?
Städte für Millionäre
Hier fühlen sich die Vermögenden am wohlsten
In diesen Ländern ist Netflix am billigsten
Wo zahlen Abonnenten am wenigsten?
mehr Top Rankings

Umfrage

Bundesjustizministerin Barley (SPD) hat vorgeschlagen, die Mietpreisbremse zu verschärfen. Was halten Sie von dieser Idee?

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Deutsche Bank AG514000
Scout24 AGA12DM8
Daimler AG710000
Apple Inc.865985
Amazon906866
Wirecard AG747206
TeslaA1CX3T
Allianz840400
BMW AG519000
SAP SE716460
BayerBAY001
E.ON SEENAG99
CommerzbankCBK100
NEL ASAA0B733
BASFBASF11